| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 29,444,404 | 30,919,117 | 36,708,440 | | Cost of Revenue | 20,776,159 | 21,673,724 | 25,710,837 | | | Gross Profit | 8,668,245 | 9,245,393 | 10,997,604 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 6,072,988 | 6,144,939 | 7,802,116 | | Non Recurring | (97,269) | (23,566) | (79,344) | | Others |
-
| 51,552 | 57,989 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,692,527 | 3,072,469 | 3,216,842 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 225,552 | 206,206 | 67,785 | | Earnings Before Interest And Taxes | 3,004,071 | 3,372,941 | 3,377,097 | | Interest Expense | 709,079 | 568,539 | 556,580 | | Income Before Tax | 2,294,992 | 2,804,402 | 2,820,516 | | Income Tax Expense | 515,950 | 686,371 | 712,525 | | Minority Interest |
-
|
-
| (27,623) | | | | Net Income From Continuing Ops | 1,779,041 | 2,118,030 | 2,080,368 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (2,351) | | Other Items |
-
|
-
|
-
| | | | Net Income | 1,779,041 | 2,118,030 | 2,078,017 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,779,041 | $2,118,030 | $2,078,017 |
|
0.51% Nasdaq 
Income Statement
